Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 23 hours ago

Indications

Lornoxicam is used for short-term relief of acute mild to moderate pain. It is also used for symptomatic relief of pain and inflammation in osteoarthritis, and for symptomatic relief of pain and inflammation in rheumatoid arthritis.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Lornoxicam is a non-steroidal anti-inflammatory drug (NSAID) and an antirheumatic drug from the oxicam class. It is meant for short-term treatment of acute mild to moderate pain. It is also used for symptoms of rheumatoid arthritis and osteoarthritis, such as pain and inflammation of the joints. Lornoxicam works mainly by blocking the synthesis of prostaglandins (it inhibits the cyclooxygenase enzyme). This desensitizes the peripheral nociceptors, and so inflammation is reduced.

Pregnancy & Breastfeeding

Lomoxicam is contraindicated in the third trimester of pregnancy. It should also not be used in the first and second trimesters or during delivery, because no clinical data on exposed pregnancies are available.

There are no data on the excretion of Lomoxicam in human breast milk. In lactating rats, it passes into the milk in relatively high concentrations. So breastfeeding women should not use Lomoxicam.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: For acute pain, adults take 8 to 16 mg Lomoxicam daily, divided into 2 or 3 doses, and the maximum recommended daily dose is 16 mg. For osteoarthritis and rheumatoid arthritis, the recommended starting dose is 12 mg Lomoxicam daily, divided into 2 or 3 doses. The maintenance dose should not go above 16 mg daily. Children and adolescents below age 18 should not use Lomoxicam, because there is a lack of data on its safety and efficacy. Elderly patients above age 65 need no special dose change, but the medicine should be given with precaution, as gastrointestinal adverse effects are less well tolerated in this group. In mild to moderate renal impairment, the maximum recommended daily dose is 12 mg, divided in 2 or 3 doses. The same limit applies in moderate hepatic impairment, so the maximum is 12 mg daily, divided in 2 or 3 doses. Undesirable effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.